Checkpoint Therapeutics Inc. (CKPT) NASDAQ
$1.63 0.07 (4.49%)
Market Cap: $54.58M
As of 05/15/24 04:00 PM EDT. Market closed.
Checkpoint Therapeutics Inc. (CKPT)
NASDAQ
$1.63
0.07 (4.49%)
Market Cap: $54.58M
As of 05/15/24 04:00 PM EDT. Market closed.
Add to Portfolio
checkpoint therapeutics, inc., an immuno-oncology biopharmaceutical company, focuses on the acquisition, development, and commercialization of novel treatments for patients with solid tumor cancers. the company's product candidates include ck-101 that in phase i clinical trial for the treatment of epidermal growth factor receptor mutation-positive non-small cell lung cancer; and cosibelimab, a ... read more
COMPANY PROFILE
Sector
Professional, Scientific, and Technical Services
Industry
Research and Development in Biotechnology (except Nanobiotechnology)
CEO Compensation (Base)
$450,000
CEO Compensation (Total)
$2.13M
Sector
Professional, Scientific, and Technical Services
Industry
Research and Development in Biotechnology (except Nanobiotechnology)
Full Time Employees
6
CEO Compensation (Base)
$450,000
CEO Compensation (Total)
$2.13M
Address
2 Gansevoort St Fl 9, New York, New York, 10014-1667.
PRICE CHART FOR CHECKPOINT THERAPEUTICS INC
From:
To:
NEWS
INSIDEARBITRAGE ARTICLES
KEY STATS
Open
$1.57
Previous Close
$1.56
Days Range
$1.55 - $1.64
52 week range
$1.30 - $3.62
Volume
260,900
Avg. Volume (30 days)
382,147
Market Cap
$54.58M
Dividend Yield
-
P/E
(1.05)
Shares Outstanding
34,986,279
Open
$1.57
Previous Close
$1.56
Days Range
$1.55 - $1.64
52 week range
$1.30 - $3.62
Volume
260,900
Avg. Volume (30 days)
382,147
Market Cap
$54.58M
Dividend Yield
-
P/E
(1.05)
Shares Outstanding
34,986,279
FINANCIAL STATEMENTS FOR CHECKPOINT THERAPEUTICS INC
LOADING...
INSIDER TRANSACTIONS FOR CHECKPOINT THERAPEUTICS INC
Owner | Relationship | Date | Transaction | Cost | # Shares | Value($) | Total Shares | Form 4 |
Oliviero James F III | CEO, President and Director | Feb 28, 2024 | Sale | $2.06 | 5,894 | 12,142 | 350,836 | Mar 01, 2024, 08:31 PM |
GRAY WILLIAM GARRETT | Chief Financial Officer | Feb 28, 2024 | Sale | $2.07 | 2,035 | 4,212 | 145,224 | Mar 01, 2024, 08:30 PM |
GRAY WILLIAM GARRETT | Chief Financial Officer | Feb 01, 2024 | Sale | $1.95 | 4,115 | 8,024 | 147,259 | Feb 02, 2024, 08:15 PM |
Oliviero James F III | CEO, President and Director | Feb 01, 2024 | Sale | $2.01 | 11,900 | 23,919 | 369,680 | Feb 02, 2024, 08:10 PM |
Oliviero James F III | CEO, President and Director | Mar 02, 2023 | Sale | $5.00 | 5,483 | 27,415 | 144,090 | Mar 03, 2023, 08:00 PM |
Oliviero James F III | CEO, President and Director | Feb 27, 2023 | Sale | $4.65 | 5,548 | 25,798 | 134,573 | Mar 03, 2023, 08:00 PM |
GRAY WILLIAM GARRETT | Chief Financial Officer | Mar 02, 2023 | Sale | $5.00 | 3,591 | 17,955 | 51,374 | Mar 03, 2023, 08:00 PM |
GRAY WILLIAM GARRETT | Chief Financial Officer | Feb 27, 2023 | Sale | $4.66 | 1,914 | 8,919 | 47,465 | Mar 03, 2023, 08:00 PM |
GRAY WILLIAM GARRETT | Chief Financial Officer | Feb 01, 2023 | Sale | $4.79 | 3,154 | 15,108 | 49,379 | Feb 03, 2023, 08:00 PM |
Oliviero James F III | CEO, President and Director | Feb 01, 2023 | Sale | $4.77 | 10,261 | 48,945 | 182,121 | Feb 03, 2023, 08:00 PM |
GRAY WILLIAM GARRETT | Chief Financial Officer | Jan 10, 2023 | Sale | $6.75 | 1,858 | 12,540 | 52,533 | Jan 12, 2023, 08:05 PM |
Oliviero James F III | CEO, President and Director | Jan 10, 2023 | Sale | $6.75 | 3,817 | 25,761 | 192,382 | Jan 12, 2023, 08:05 PM |
Oliviero James F III | CEO, President and Director | Jun 23, 2022 | Sale | $1.11 | 15,000 | 16,650 | 2,562,003 | Jul 01, 2022, 09:30 PM |
Oliviero James F III | CEO, President and Director | Jun 22, 2022 | Sale | $1.09 | 12,000 | 13,080 | 2,577,003 | Jul 01, 2022, 09:30 PM |
Oliviero James F III | CEO, President and Director | Jun 21, 2022 | Sale | $1.09 | 21,000 | 22,890 | 2,589,003 | Jul 01, 2022, 09:30 PM |
Oliviero James F III | CEO, President and Director | Jun 17, 2022 | Sale | $1.09 | 228,000 | 248,520 | 2,610,003 | Jul 01, 2022, 09:30 PM |
Oliviero James F III | CEO, President and Director | Jan 01, 2022 | Option Exercise | $3.11 | 302,777 | 941,636 | 3,305,433 | Apr 22, 2022, 08:31 PM |
Oliviero James F III | CEO, President and Director | Feb 24, 2022 | Option Exercise | $1.85 | 117,657 | 217,665 | 2,959,644 | Apr 22, 2022, 08:31 PM |
Oliviero James F III | CEO, President and Director | Jan 30, 2022 | Option Exercise | $2.46 | 31,972 | 78,651 | 3,077,301 | Apr 22, 2022, 08:31 PM |
Oliviero James F III | CEO, President and Director | Jan 24, 2022 | Option Exercise | $2.19 | 143,136 | 313,468 | 3,109,273 | Apr 22, 2022, 08:31 PM |
Oliviero James F III | CEO, President and Director | Jan 06, 2022 | Option Exercise | $2.77 | 53,024 | 146,876 | 3,252,409 | Apr 22, 2022, 08:31 PM |
Oliviero James F III | CEO, President and Director | Apr 05, 2022 | Sale | $1.77 | 14,030 | 24,833 | 2,859,261 | Apr 22, 2022, 08:31 PM |
Oliviero James F III | CEO, President and Director | Apr 04, 2022 | Sale | $1.79 | 86,353 | 154,572 | 2,873,291 | Apr 22, 2022, 08:31 PM |
Oliviero James F III | CEO, President and Director | Apr 13, 2022 | Sale | $1.51 | 21,258 | 32,100 | 2,838,003 | Apr 22, 2022, 08:31 PM |
GRAY WILLIAM GARRETT | Chief Financial Officer | Mar 10, 2022 | Sale | $1.89 | 38,197 | 72,307 | 543,910 | Mar 11, 2022, 07:30 PM |
GRAY WILLIAM GARRETT | Chief Financial Officer | Feb 01, 2022 | Sale | $2.51 | 37,063 | 92,954 | 582,107 | Feb 02, 2022, 07:01 PM |
Oliviero James F III | CEO, President and Director | Feb 05, 2021 | Sale | $3.42 | 48,790 | 166,745 | 3,153,210 | Feb 05, 2021, 08:16 PM |
Oliviero James F III | CEO, President and Director | Feb 04, 2021 | Sale | $3.51 | 70,000 | 245,525 | 3,202,000 | Feb 05, 2021, 08:16 PM |
GRAY WILLIAM GARRETT | Chief Financial Officer | Feb 04, 2021 | Sale | $3.66 | 26,320 | 96,318 | 482,170 | Feb 05, 2021, 08:16 PM |
GRAY WILLIAM GARRETT | Chief Financial Officer | Dec 22, 2020 | Sale | $2.79 | 2,406 | 6,712 | 357,490 | Dec 23, 2020, 09:30 PM |
GRAY WILLIAM GARRETT | See Remarks | May 21, 2020 | Sale | $2.00 | 17,104 | 34,122 | 359,896 | May 22, 2020, 05:00 PM |
ROSENWALD LINDSAY A MD | Director | Nov 20, 2019 | Buy | $1.27 | 100,000 | 127,000 | 237,890 | Nov 22, 2019, 08:00 AM |
ROSENWALD LINDSAY A MD | Director | Nov 09, 2018 | Buy | $2.35 | 49,666 | 116,715 | 126,448 | Nov 13, 2018, 12:23 PM |
ROSENWALD LINDSAY A MD | Director | Nov 08, 2018 | Buy | $2.24 | 48,234 | 108,044 | 76,782 | Nov 13, 2018, 12:23 PM |
ROSENWALD LINDSAY A MD | Director | Nov 07, 2018 | Buy | $2.12 | 2,100 | 4,452 | 28,548 | Nov 13, 2018, 12:23 PM |
Load More Insider Transactions
Buy
Sale
Option Exercise
Owner | Relationship | Date | Value($) |
Oliviero James F III | CEO, President and Director | 02/28/2024 | 12,142 |
GRAY WILLIAM GARRETT | Chief Financial Officer | 02/28/2024 | 4,212 |
GRAY WILLIAM GARRETT | Chief Financial Officer | 02/01/2024 | 8,024 |
Oliviero James F III | CEO, President and Director | 02/01/2024 | 23,919 |
Oliviero James F III | CEO, President and Director | 03/02/2023 | 27,415 |
Oliviero James F III | CEO, President and Director | 02/27/2023 | 25,798 |
GRAY WILLIAM GARRETT | Chief Financial Officer | 03/02/2023 | 17,955 |
GRAY WILLIAM GARRETT | Chief Financial Officer | 02/27/2023 | 8,919 |
GRAY WILLIAM GARRETT | Chief Financial Officer | 02/01/2023 | 15,108 |
Oliviero James F III | CEO, President and Director | 02/01/2023 | 48,945 |
GRAY WILLIAM GARRETT | Chief Financial Officer | 01/10/2023 | 12,540 |
Oliviero James F III | CEO, President and Director | 01/10/2023 | 25,761 |
Oliviero James F III | CEO, President and Director | 06/23/2022 | 16,650 |
Oliviero James F III | CEO, President and Director | 06/22/2022 | 13,080 |
Oliviero James F III | CEO, President and Director | 06/21/2022 | 22,890 |
Oliviero James F III | CEO, President and Director | 06/17/2022 | 248,520 |
Oliviero James F III | CEO, President and Director | 01/01/2022 | 941,636 |
Oliviero James F III | CEO, President and Director | 02/24/2022 | 217,665 |
Oliviero James F III | CEO, President and Director | 01/30/2022 | 78,651 |
Oliviero James F III | CEO, President and Director | 01/24/2022 | 313,468 |
Oliviero James F III | CEO, President and Director | 01/06/2022 | 146,876 |
Oliviero James F III | CEO, President and Director | 04/05/2022 | 24,833 |
Oliviero James F III | CEO, President and Director | 04/04/2022 | 154,572 |
Oliviero James F III | CEO, President and Director | 04/13/2022 | 32,100 |
GRAY WILLIAM GARRETT | Chief Financial Officer | 03/10/2022 | 72,307 |
GRAY WILLIAM GARRETT | Chief Financial Officer | 02/01/2022 | 92,954 |
Oliviero James F III | CEO, President and Director | 02/05/2021 | 166,745 |
Oliviero James F III | CEO, President and Director | 02/04/2021 | 245,525 |
GRAY WILLIAM GARRETT | Chief Financial Officer | 02/04/2021 | 96,318 |
GRAY WILLIAM GARRETT | Chief Financial Officer | 12/22/2020 | 6,712 |
GRAY WILLIAM GARRETT | See Remarks | 05/21/2020 | 34,122 |
ROSENWALD LINDSAY A MD | Director | 11/20/2019 | 127,000 |
ROSENWALD LINDSAY A MD | Director | 11/09/2018 | 116,715 |
ROSENWALD LINDSAY A MD | Director | 11/08/2018 | 108,044 |
ROSENWALD LINDSAY A MD | Director | 11/07/2018 | 4,452 |
Load More Insider Transactions
FUNDS WITH A POSITION IN CHECKPOINT THERAPEUTICS INC
Fund | # Shares Owned | % of Portfolio | % Change | Investing Style |
---|---|---|---|---|
RENAISSANCE TECHNOLOGIES LLC | 271,217 | 0.00087% | 63.65% | Other |
GEODE CAPITAL MANAGEMENT, LLC | 198,501 | 0.00004% | 14.18% | Other |
BLACKROCK INC. | 165,444 | 0.00001% | -0.64% | Other |
D. E. SHAW & CO., INC. | 108,612 | 0.00019% | -22.72% | Other |
CHANGE IN SHARES OUTSTANDING FOR CHECKPOINT THERAPEUTICS INC
STOCK BUYBACKS FOR CHECKPOINT THERAPEUTICS INC
Period of Report: 12/31/2023
10-K/10-Q Filings: View
Previous Period
% Change in Shares
Quarter
09/30/2023
-6.23%
1Q
06/30/2023
19.38%
2Q
BUYBACK ANNOUNCEMENT(S) FOR CHECKPOINT THERAPEUTICS INC
LOADING...